Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium

A. Fahrleitner-Pammer, N. Papaioannou, E. Gielen, M. Feudjo Tepie, C. Toffis, I. Frieling, P. Geusens, P. Makras, E. Boschitsch, J. Callens, A. D. Anastasilakis, C. Niedhart, H. Resch, L. Kalouche-Khalil, P. Hadji*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number58
Number of pages13
JournalArchives of Osteoporosis
Volume12
Issue number1
DOIs
Publication statusPublished - 22 Jun 2017

Keywords

  • Adherence
  • Compliance
  • Denosumab
  • Non-interventional study
  • Osteoporosis
  • Persistence
  • LONG-TERM PERSISTENCE
  • RANDOMIZED-OPEN-LABEL
  • ORAL BISPHOSPHONATES
  • BONE TURNOVER
  • MEDICATION ADHERENCE
  • ALENDRONATE THERAPY
  • UNITED-STATES
  • FRACTURES
  • EFFICACY
  • SAFETY

Cite this

Fahrleitner-Pammer, A., Papaioannou, N., Gielen, E., Tepie, M. F., Toffis, C., Frieling, I., Geusens, P., Makras, P., Boschitsch, E., Callens, J., Anastasilakis, A. D., Niedhart, C., Resch, H., Kalouche-Khalil, L., & Hadji, P. (2017). Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Archives of Osteoporosis, 12(1), [58]. https://doi.org/10.1007/s11657-017-0351-2